Regulacje i polityka gospodarcza · 06/11/2009
Availability for Licensing of Live Bubonic Plague Vaccine Patent Application
The US Government, represented by the Secretary of the Army, has made the patent application for a live bubonic plague vaccine based on Yersinia Pestis gene deletion available for non-exclusive, exclusive, or partially exclusive licensing.